APC/Cy7 Linked Polyclonal Antibody to Myosin Heavy Chain 7, Cardiac Muscle, Beta (MYH7)

Référence MBS2109987-5mL

Conditionnement : 5mL

Marque : MyBiosource

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Myosin Heavy Chain 7 (MYH7) Antibody – Rabbit Polyclonal

For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2109987
SPECIAL PROMOTION: Get FREE Starbucks gift card (Maximum 5 gift cards/product). Gift card(s) will be included with shipment

MBS2109987 is an antibody targeting MYH7. Also known as APC/Cy7 Linked Polyclonal Antibody to Myosin Heavy Chain 7, Cardiac Muscle, Beta (MYH7). Reactive in Human, Pig, Bovine. Host: Rabbit. More details

Product Overview

Product Name
Myosin Heavy Chain 7 (MYH7), Polyclonal Antibody
Full Product Name
APC/Cy7 Linked Polyclonal Antibody to Myosin Heavy Chain 7, Cardiac Muscle, Beta (MYH7)
Product Gene Name
anti-MYH7 antibody
Product Synonym Names
CMD1S; CMH1; MPD1; MYHCB; Myopathy, Distal 1; Myosin heavy chain slow isoform; Myosin heavy chain, cardiac muscle beta isoform
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Human, Pig, Bovine
Form/Format
Liquid
Purity/Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Concentration
>=100ug/ml (lot specific)
Specificity
The antibody is a rabbit polyclonal antibody raised against MYH7. It has been selected for its ability to recognize MYH7 in immunohistochemical staining and western blotting.
Preparation and Storage
Store at 4 degree C for frequent use. Aliquot and store at -20 degree C for 12 months.
Avoid repeated freeze/thaw cycles.

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 degree C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Matching Pairs
APC-CY7 Conjugated Antibody: MYH7 (MBS2109987)
Immunogen: MYH7 (MBS2123080)
Matching Pairs
Unconjugated Antibody: MYH7 (MBS2111414)
APC-CY7 Conjugated Antibody: MYH7 (MBS2109987)
OMIM
160500
3D Structure
ModBase 3D Structure for P12883
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
Conjugation
APC-Cy7
Cross Reactivity
Human
ISO Certification
Manufactured in an ISO 9001:2015 and ISO 13485:2016 Certified Laboratory.
Applications Tested/Suitable for anti-MYH7 antibody
Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)

Other Notes

Small volumes of anti-MYH7 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for MYH7. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Related Accession #
NCBI Official Full Name
Myosin-7
NCBI Official Synonym Full Names
myosin heavy chain 7
NCBI Official Symbol
MYH7
NCBI Official Synonym Symbols
CMH1; MPD1; SPMD; SPMM; CMD1S; MYHCB
UniProt Protein Name
Myosin-7
UniProt Synonym Protein Names
Myosin heavy chain 7; Myosin heavy chain slow isoform; MyHC-slow; Myosin heavy chain, cardiac muscle beta isoform
Protein Family
Myosin
UniProt Gene Name
MYH7
UniProt Synonym Gene Names
MYHCB; MyHC-slow; MyHC-beta
UniProt Entry Name
MYH7_HUMAN
NCBI Protein Information
myosin-7

NCBI Summary for MYH7

Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008]
Show more

UniProt Comments for MYH7

MYH7: Muscle contraction. Defects in MYH7 are the cause of familial hypertrophic cardiomyopathy type 1 (CMH1). Familial hypertrophic cardiomyopathy is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. Defects in MYH7 are the cause of myopathy myosin storage (MYOMS). In this disorder, muscle biopsy shows type 1 fiber predominance and increased interstitial fat and connective tissue. Inclusion bodies consisting of the beta cardiac myosin heavy chain are present in the majority of type 1 fibers, but not in type 2 fibers. Defects in MYH7 are the cause of scapuloperoneal myopathy MYH7-related (SPMM); also known as scapuloperoneal syndrome myopathic type. SPMM is a progressive muscular atrophia beginning in the lower legs and affecting the shoulder region earlier and more severely than distal arm. Defects in MYH7 are a cause of cardiomyopathy dilated type 1S (CMD1S). Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. Defects in MYH7 are the cause of myopathy distal type 1 (MPD1). MPD1 is a muscular disorder characterized by early-onset selective weakness of the great toe and ankle dorsiflexors, followed by weakness of the finger extensors. Mild proximal weakness occasionally develops years later after the onset of the disease.

Protein type: Motor; Motility/polarity/chemotaxis

Chromosomal Location of Human Ortholog: 14q12

Cellular Component: nucleoplasm; sarcomere; focal adhesion; cytoplasm; stress fiber; muscle myosin complex; Z disc; myosin complex

Molecular Function: calmodulin binding; microfilament motor activity; protein binding; ATPase activity; actin-dependent ATPase activity; actin binding; ATP binding

Biological Process: adult heart development; striated muscle contraction; muscle contraction; regulation of heart rate; metabolic process; ventricular cardiac muscle morphogenesis; regulation of the force of heart contraction; muscle filament sliding

Disease: Myopathy, Distal, 1; Scapuloperoneal Myopathy, Myh7-related; Myopathy, Myosin Storage; Cardiomyopathy, Dilated, 1s; Myopathy, Congenital, With Fiber-type Disproportion; Cardiomyopathy, Familial Hypertrophic, 1; Myopathy, Myosin Storage, Autosomal Recessive
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Pathways associated with anti-MYH7 antibody

 Products by Pathway  Pathway Diagram
 Adrenergic Signaling In Cardiomyocytes Pathway antibodies  Adrenergic Signaling In Cardiomyocytes Pathway Diagram
 Adrenergic Signaling In Cardiomyocytes Pathway antibodies  Adrenergic Signaling In Cardiomyocytes Pathway Diagram
 Cardiac Muscle Contraction Pathway antibodies  Cardiac Muscle Contraction Pathway Diagram
 Cardiac Muscle Contraction Pathway antibodies  Cardiac Muscle Contraction Pathway Diagram
 Dilated Cardiomyopathy Pathway antibodies  Dilated Cardiomyopathy Pathway Diagram
 Dilated Cardiomyopathy Pathway antibodies  Dilated Cardiomyopathy Pathway Diagram
 Hypertrophic Cardiomyopathy (HCM) Pathway antibodies  Hypertrophic Cardiomyopathy (HCM) Pathway Diagram
 Hypertrophic Cardiomyopathy (HCM) Pathway antibodies  Hypertrophic Cardiomyopathy (HCM) Pathway Diagram
 Membrane Trafficking Pathway antibodies  Membrane Trafficking Pathway Diagram
 Tight Junction Pathway antibodies  Tight Junction Pathway Diagram

Diseases associated with anti-MYH7 antibody

 Disease Name  Pubmed Publications
 Cardiovascular Diseases Antibodies  >242 publications with MYH7 and Cardiovascular Diseases
 Heart Diseases Antibodies  >240 publications with MYH7 and Heart Diseases
 Cardiomyopathy, Hypertrophic Antibodies  >220 publications with MYH7 and Cardiomyopathy, Hypertrophic
 Cardiomyopathies Antibodies  >217 publications with MYH7 and Cardiomyopathies
 Hypertrophy Antibodies  >101 publications with MYH7 and Hypertrophy
 Cardiomyopathy, Hypertrophic, Familial Antibodies  >92 publications with MYH7 and Cardiomyopathy, Hypertrophic, Familial
 Cardiomegaly Antibodies  >57 publications with MYH7 and Cardiomegaly
 Cardiomyopathy, Dilated Antibodies  >52 publications with MYH7 and Cardiomyopathy, Dilated
 Hypertrophy, Left Ventricular Antibodies  >45 publications with MYH7 and Hypertrophy, Left Ventricular
 Heart Failure Antibodies  >44 publications with MYH7 and Heart Failure

Organs/Tissues associated with anti-MYH7 antibody

 Organ/Tissue Name  Pubmed Publications
 Muscle Antibodies  >183 publications with MYH7 and Muscle
 Heart Antibodies  >159 publications with MYH7 and Heart
 Embryonic Tissue Antibodies  >9 publications with MYH7 and Embryonic Tissue
 Brain Antibodies  >8 publications with MYH7 and Brain
 Eye Antibodies  >6 publications with MYH7 and Eye
 Lung Antibodies  >5 publications with MYH7 and Lung
 Nerve Antibodies  >3 publications with MYH7 and Nerve
 Thyroid Antibodies  >3 publications with MYH7 and Thyroid
 Liver Antibodies  >2 publications with MYH7 and Liver
 Testis Antibodies  >2 publications with MYH7 and Testis